Presentation is loading. Please wait.

Presentation is loading. Please wait.

AKUMS DRUGS & PHARMACEUTICALS LTD.

Similar presentations


Presentation on theme: "AKUMS DRUGS & PHARMACEUTICALS LTD."— Presentation transcript:

1 AKUMS DRUGS & PHARMACEUTICALS LTD.
D. C . JAIN

2 WHAT IS COVERED UNDER DPCO - 2013

3 Covered under DPCO 1. SCHEDULED DRUGS : Strength & Dosage Forms of 348 drugs in Schedule 1 Those selling at higher MRP shall bring down their MRP as notified by NPPA. Those selling at lower MRP shall not increase their MRP as per notified price; but will Continue to sell at their existing price.

4 Covered under DPCO 2. NEW DRUGS as defined under 2(u) ; Applicable to Existing Manufacturers for launch of New Drug and will require price approval. 3. IMPORTED DRUGS: ceiling price shall be as applicable on indigenous drugs

5 Covered under DPCO 4. Monitoring of MRP of NON – SCHEDULED DRUGS (only 10% price increase per Annum allowed) 5. Control over BULK DRUGS MANUFACTURER For bulk drug availability in case of emergency, urgency, non-commercial use, public interest. 6. Control over FORMULATION MANUFACTURER Directing for supply of formulations to sell to institutions, hospitals or agencies.

6 7. Control over FORMULATION MANUFACTURER
Covered under DPCO 7. Control over FORMULATION MANUFACTURER Directing not to stop manufacturing or reduce manufacturing of required quantities of formulation covered under NLEM.

7 Covered under DPCO 8. Pricing of formulations covered under DPCO shall remain valid upto or 1 year from date of issue and thereafter prices can be increased as per annual whole sale price index for previous calendar year (2012) and thereafter formula as per para 4(1) shall be applied.

8 Covered under DPCO 10. Profit margin to retailers fixed 16% on retail price on scheduled formulations and New Drugs. 11. Ceiling Price / Retail Price will be notified on the basis of dosage unit – Per Tab / Per Cap / Per Vial. 12. Deposit of over charged amount with interest and penalty. 13. Power of entry, search and seizure by any Gazetted officer.

9 WHAT IS NOT COVERED UNDER DPCO - 2013

10 NOT Covered under DPCO 1. Ayurvedic, Siddha, Unani Medicines. 2. Homoeopathic Medicines. 3. Any Substance not covered under Drugs & Cosmetics Act. 4. Non-Scheduled Drugs. 5. Non-Scheduled Drug combined with non schedule drug.

11 NOT Covered under DPCO 6. Non-Scheduled Drugs – when combined with a Schedule Drug with different strength. 7. Non-Scheduled Drugs – when combined with a Schedule Drug with different dosage form. 8. New Drugs Manufactured by a New Manufacturer, New Drug already being manufactured by an existing Manufacturer.

12 NOT Covered under DPCO 9. A formulation defined as New Drug involving NDDS under rule 122E of D&C Act and for which DCGI has granted its approval for five years from the date of its approval. 10. Patented Drug (Product Patent or process patent or new drug delivery system) for five Years.

13 NOT Covered under DPCO 11. All innovations in dosage as SR, ER, etc., unless already specified in Schedule; a separate manufacturing licence has been granted as such.

14 WHAT IS SCHEDULED DRUG / FORMULATIONS

15 “Scheduled Drug/Formulation”
Scheduled Drugs “Scheduled Drug/Formulation” consisting of 348 drugs / 652 formulations Under 27 therapeutics mentioned in First Schedule appended to DPCO 2013 With same strength and With same dosage forms, Whether referred to by generic version or By brand name.

16 As per NPPA clarification Paracetamol Syrup and Paracetamol Suspension
Scheduled Drugs As per NPPA clarification Paracetamol Syrup and Paracetamol Suspension are same DOSGAE FORMS And therefore same ceiling price is applicable

17 Amoxicillin capsules 250mg and 500mg are covered under schedule:
Scheduled Drugs 2. If Strength of a scheduled formulation is changed, it ceases to be a Scheduled drugs e.g. – Amoxicillin capsules 250mg and 500mg are covered under schedule: Amoxicillin capsules 125mg shall not be called a Scheduled Drug

18 Amoxicillin Capsules 250mg is covered under schedule:
Scheduled Drugs 3. If Dosage Form of a scheduled formulation is changed, it ceases to be a Scheduled Drugs e.g. --- Amoxicillin Capsules 250mg is covered under schedule: Amoxicillin Tablet 250mg shall not be called a Scheduled Drug

19 Amoxicillin Capsules 250mg is covered under schedule
Scheduled Drugs 4. If Dosage Form & Strength of a scheduled formulation are changed, it ceases to be a Scheduled Drugs e.g. --- Amoxicillin Capsules 250mg is covered under schedule Amoxicillin Tablet 125mg shall not be called a Scheduled Drug

20 5. Scheduled Drug shall mean Formulation with Same strength and
Same dosage form as in the schedule and nothing else.

21 WHAT IS NON-SCHEDULED DRUG / FORMULATIONS

22 Non - Scheduled Drugs 1. What is not a Scheduled Drug is a NON- SCHEDULED DRUG 2. Under para 2(v), “Non-Scheduled Formulation” means a formulation, containing the molecule, the dosage and strengths of which are not specified in the First Schedule; (Non-NLEM Drug / Formulation) For Example: Aceclofenac, Nimusulide, Sildenafil Citrate, Norfloxocin, Rabeprazole

23 WHAT IS NEW DRUG

24 New Drug / New Formulation
Under para 2(u) of DPCO 2013, New Drug has been defined as under: “New Drug” for the purposes of this Order shall mean a formulation launched by an Existing manufacturer of a drug of specified dosages and strengths as listed in the National List of Essential Medicines (NLEM Formulation) by combining the drug with another drug either listed or not listed in the National List of Essential Medicines or a formulation launched by changing the strength or dosages or both of the same drug of specified dosages and strengths as listed in the NLEM List.

25 New Drug / New Formulation concept is applicable to
“Existing Manufacturer” and Not to a “New Manufacturer” Concept is applicable at the launch of new drug and Not for existing formulations under production, even if covered under the definition of New Drug.

26 New Drug New Drug / New Formulation, in simple words covers - a. NLEM Formulations with same specified dosage and strength as combined with another NLEM Formulations with same specified dosage and strength.

27 New Drug Example 1: Paracetamol 500mg Tablet is Scheduled Formulation Diclofenac 50mg Tablet is Scheduled Formulation Paracetamol 500mg + Diclofenac 50mg Tablet is New Drug/Formulation

28 New Drug Example 2: Omaprazole 20mg Tablet is Scheduled Drug Domperadone 10mg Tablet is Scheduled Drug Omaprazole 20mg + Domperadone 10mg Tablet is New Drug

29 New Drug Example 3: Cefixime 100mg Tablet is Scheduled Drug Ofloxacin 100mg Tablet is Scheduled Drug Cefixime 100mg + Ofloxacin 100mg Tablet is New Drug

30 New Drug Example 4: Vitamin A 5000IU Capsule is Scheduled Formulation. Vitamin D 0.25mg Capsule Vitamin A 5000IU + Vitamin D 0.25mg Capsule is New Drug.

31 Non - NLEM Formulations
New Drug b. NLEM Formulations with same specified dosage and strength as combined with another Non - NLEM Formulations

32 New Drug Example 1: Paracetamol 500mg Tablet is Scheduled Formulation Aceclofenac 100mg Tablet is Non - Scheduled Formulation Paracetamol 500mg + Aceclofenac 100mg Tablet is New Drug

33 New Drug Example 2: Diclofenac Sodium 50mg Tablet is a Scheduled Formulation Serratiopeptidase 10mg Tablet is Non-Scheduled Drugs Diclofenac Sodium 50mg + Serratiopeptidase 10mg Tablet is New Drug

34 New Drug Example 3: Clopidogrel 75 mg Tablet is a Scheduled Formulation Aspirin 75 mg is Non-Scheduled Drugs Clopidogrel 75 mg + Aspirin 75 mg Tablet is New Drug

35 New Drug c. NLEM Formulations by changing its strength Example 1: Paracetamole 500mg Tablet is a Scheduled Drug Paracetamole 325mg Tablet is a New Drug Example 2: Clopidogrel 75 mg Tablet is a Scheduled Drug Clopidogrel 150 mg Tablet is a New Drug

36 New Drug d. NLEM Formulations by changing its dosage form -- Example 1: Diclofenac 50mg Tablet is a Scheduled Drug. Diclofenac 50mg Ointment is a New Drug. Example 2: Clopidogrel 75 mg Tablet is a Scheduled Drug. Clopidogrel 75 mg Capsule is a New Drug.

37 New Drug e. NLEM Formulations by changing its strength and dosage form Example 1: Diclofenac 50mg Tablet is a Scheduled Drug. Diclofenac 30mg Ointment is a New Drug. (Strength and Dosage Form Both Changed)

38 New Drug Example 2: Tramadol 50 mg / ml Injection is a Scheduled Drug. Tramadol 37.5 mg tablets is a New Drug (Strength and Dosage Form Both Changed) However if New Drug using NDDS and has approval from DCGI then DPCO is not applicable for 5 years.

39 New Drug Example 3: Metformin Tab 500mg is a Schedule Drug Metformin Tab 500mg SR is a New Drug and will be exempted under DPCO for 5 yrs after DCGI approval.

40 New Drug Example 4: Tramadol SR or ER Tab Paracetamol SR or ER Tab Are not covered under DPCO

41 WHAT IS NOT A NEW DRUG

42 Not a New Drug Example 1: Paracetamole 500mg is Scheduled Drug Aceclofenac 100mg is not Scheduled Drug Paracetamole 325mg + Aceclofenac 100mg is not Scheduled Drug and is not a New Drug under DPCO for price approval

43 Not a New Drug Example 2: Paracetamole 500mg is Scheduled Drug Nimusulide 100mg is not Scheduled Drug Paracetamole 325mg + Nimusulide 100mg is not Scheduled Drug and is not a New Drug under DPCO for price approval

44 DEFINITION OF MANUFACTURER & EXISTING MANUFACTURER

45 WHO IS EXISTING MANUFACTURER?
Under Para 2 (g) of DPCO 2013, “Existing Manufacturer” means Manufacturer Existing on the Date of Publication of DPCO 2013 in the official gazette.

46 Manufacturer Under para 2(o) Drug Price Control order 2013 Manufacturer has been defined as under: “Manufacturer” for the purpose of this order means any person who manufactures, imports and markets drugs for distribution or sale in the country.

47 Manufacturer For the purpose of DPCO, following persons shall be manufacturers in India: i) A manufacturer, who himself markets drugs for distribution or sale ii) An Importer, who markets drugs for distribution or sale iii) A marketer who markets drugs for distribution or sale after getting drugs mfd. By a contract manufacture.

48 Manufacturer A Contract Manufacturer who is not a marketer, is not manufacturer under DPCO 2013.

49 PRICES DEFINED

50 1. PRICE TO RETAILER Price to Retailer mean price of a drug at which it is sold to a retailer which includes duties and does not include local taxes. Price to Retailer is retail price fixed by Govt. As divided by 1.16 or say % of Retail Price.

51 2. CEILING PRICE Ceiling Price means price fixed by Govt.Under DPCO. Ceiling Price shall include Retailers Markup / profit margin of 16% over purchase price of retailer

52 3. MAXIMUM RETAIL PRICE Maximum Retail Price means ceiling price or retail price + local taxes & duties as applicable at which drug shall be sold to the ultimate consumer and where such price is mentioned on the pack.

53 PRICES CALCULATIONS

54 CALCULATION OF PRICE Discussion of DPCO Price Fixation was confined to NLEM Formulations with specified dosage and specified strength only. Now a parallel DPCO has been created to cover new drugs, for taking price approval in case of new launch by an existing manufacturer.

55 Calculation of Ceiling Price of a Scheduled Formulation
a. Average Price to Retailer P(s) (Sum of prices to retailer of all the brands and generic versions of the medicine having market share more than or equal to one percent of the total market turnover on the basis of moving annual turnover of that medicine) / (Total number of such brands and generic versions of the medicine)

56 For working out the average price, all marketed brands of a company having market share more than 1% taken considered together – Alembic case

57 Calculation of Ceiling Price of a Scheduled Formulation
b. It must be noted that Govt. has not taken Retail Price Base, but has taken Price to Retailer Base, which would mean that average MRP would come down. c. Retailers would get a markup of 16% on their purchase price and they will not get % on Retail Price.

58 Calculation of Ceiling Price of a Scheduled Imported Formulation
Ceiling Prices are calculated and notified by Govt. as per formula above shall also be applicable to Scheduled Imported Formulations

59 Calculation of retail price of a new drug for existing manufacturers of scheduled formulations:-
If such new drug is available in domestic market, the retail price shall be calculated in the same manner i.e. as per Scheduled Formulations.

60 Calculation of retail price of a new drug for existing manufacturers of scheduled formulations:-
If such new drugs are not available in domestic market, the price to retailer shall be fixed based on principals of Pharmacoeconomics by Govt. on the recommendation of standing committee of experts. 16% margin of retailer shall be added thereon for the purpose of fixing retail price.

61 Calculation of Ceiling price of a scheduled formulation in case of no reduction in price due to absence of competition Ceiling Prices in such case shall be fixed as per para 6 of the order

62 Calculation of ceiling price by existing manufacturer selling the products at a price lower than the ceiling price + taxes Under rule 13(2) such manufacturers shall maintain their existing maximum retail price

63 Calculation of Ceiling Price of Drugs Covered Under DPCO 1995
Formulations covered in Schedule –I of DPCO 2013 and also under DPCO 1995, prices of which were fixed up to ; such prices shall be applicable up to Thereafter i.e. from such prices will be increased in tandem with whole sale price Index of previous calendar year i.e

64 Calculation of Ceiling Price of Drugs Covered Under DPCO 1995
Formulations covered in Schedule –I of DPCO 2013 and also under DPCO 1995, prices of which were fixed after ; such prices shall remain applicable for 1 year from the date of such notification(s). Thereafter these prices will be increased from respective dates in tandem with whole sale price Index of previous calendar year.

65 Calculation of Ceiling Price of Drugs Covered Under DPCO 1995
Formulations not covered in Schedule –I of DPCO 2013, but covered under DPCO 1995, prices of which were fixed up to ; such prices shall remain applicable up to Thereafter i.e. from ; such formulations will because Non-Schedule Drugs and prices can be increased by 10%.

66 Calculation of Ceiling Price of Drugs Covered Under DPCO 1995
Formulations not covered in Schedule –I of DPCO 2013, but covered under DPCO 1995, prices of which were fixed after ; such prices shall remain applicable for 1 year from the date of such notification; and thereafter such formulations will become NSD and prices can be increased by 10% from the respective dates.

67 MISCELLANEOUS PROVISIONS

68 1. Calculation of Retail Price of a Pack (Rule 11)
Average Price to retailer shall be calculated on the dosage bases i.e. per tablet, per capsule, per injection or per ml in volume as listed in first schedule. 2. Therefore, bigger the pack, more will be the gain.

69 3. Who has to maintain records for inspection under DPCO
Manufacturer – YES Retailers / Wholesalers - NO

70 4. Power of Search & Seizer
Powers to be sparing used But any place; by any authorised person How much overcharging is possible for formulations produced before New Price notifications To the extent seized and not what was produced

71 5. Govt. Power under DPCO Power given to Gazetted Officers of Central & State Government to enter and seize drugs. Overcharging + Interest + Penalties provided. Earlier penalties were not there. Controlled price will be revised every five years or when NLEM is updated or revised or when there is a significant change in market structure.

72 6. Power of drug inspectors
If Drugs Inspectors are given power as Gazetted officers under DPCO – Concerned D.I. can inspect the records of manufacturer and not of Retailer

73 7. Quantum of current overcharging
Presently overcharging + Interest + Penalty are recoverable From Manufacturer Only on stocks held and sold by manufacturer only

74 Applicability of New Drug price approval is for Existing Manufacturer only.
There is no applicability of price approval of ‘New Drug’ by new manufacturer.

75 9. DPCO going beyond its scope
It is observed that under Section 12.3 Anti-hypertensive Medicines against Atnelol 50mg tablet is only specified but in the Schedule 1 under DPCO, 2013 both 50mg and 100mg tablets are specified. 100mg tablet as such be omitted from Schedule 1 of DPCO, 2013 as there was no mandate to include it. There may be other such examples; which requires further examination.

76 New Drug Vide S.O 2534 (E) Fixed the price of Cefexime Ofloxacin Tablet Rs 5.73 per tab While combination is not a Scheduled Drug. Ceiling Price Fixed for Cefexime 100 mg is Rs.7.69 per tab and Ofloxacin 100 mg is Rs. 3.30

77 PRICE REVISION

78 PRICE REVISIONS i) In case of Scheduled Drugs and New Drugs – Increase or Decrease is allowed as per whole sale price index of previous calendar year and such increase shall be applicable from 1st April each year. Govt. will issue such ceiling price also.

79 PRICE REVISIONS ii) In case of Non-Scheduled drugs – upto 10% increase every 12 calendar months is allowed. iii) In case of Scheduled Drugs so being sold by existing manufacturers at a price lower than the ceiling price fixed, increase in the existing price shall be allowed annually as per whole sale price index.

80 SCHEDULE – II FORMS

81 FORM-I Application for Fixation / Revision of a New Drug para 2(u), 5,7,8,9,15 FORM-II Submission of Revised Prices for Scheduled Formulations (Para16) FORM-III Quarterly Return for production import & sale of NLEM Drugs para 21(1) FORM-IV Application for Discontinuation / Import of Scheduled Formulations para 21 (2) FORM-V Performa for Price List (para 2(x), 24, 25, 26)

82

83

84

85

86

87 AKUMS DRUGS & PHARMACEUTICALS LTD.
D.C. JAIN AKUMS DRUGS & PHARMACEUTICALS LTD.


Download ppt "AKUMS DRUGS & PHARMACEUTICALS LTD."

Similar presentations


Ads by Google